AMN Healthcare Services Inc
Description
AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.
About
CEO
Ms. Caroline Sullivan Grace
Employees
3,585
Instrument type
Common Stock
Sector
Healthcare
Industry
Medical Care Facilities
MIC code
XNYS
Address
8840 Cypress Waters Boulevard, Dallas, TX 75019, United States
×
![Enlarged Chart]()
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 5, 2025 | — | — | — | — |
| Aug 7, 2025 | — | — | — | — |
| May 7, 2025 | — | — | — | — |
| Feb 21, 2025 | 0.58 | — | — | — |
| Feb 13, 2025 | 0.58 | — | — | — |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 8 | — | 9 |
| Average estimate | — | 0.31 | — | 1.49 |
| Low estimate | — | 0.20 | — | 1.14 |
| High estimate | — | 0.38 | — | 1.81 |
| Last year EPS | — | 0.97 | — | 3.04 |
[stock_revenue_estimate]
Growth estimates
Current qtr
-63.030%
Next qtr. (Mar 2025)
-68.120%
Current year
-62.930%
Next year (Dec 2025)
-50.970%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 3.79B | 5.24B | 3.98B | 2.39B | 2.22B |
| Cost of revenue | 2.54B | 3.53B | 2.67B | 1.60B | 1.48B |
| Gross profit | 1.25B | 1.72B | 1.31B | 791.78M | 743.47M |
| Operating expense | |||||
| Research & development | — | — | — | — | — |
| Selling general and admin | 756.24M | 936.58M | 730.45M | 549.75M | 508.03M |
| Other operating expenses | — | — | — | — | — |
| Operating income | 338.43M | 647.10M | 478.00M | 149.27M | 176.92M |
| Non operating interest income | |||||
| Income | — | — | — | — | — |
| Expense | 54.14M | 40.40M | 34.08M | 57.74M | 28.43M |
| Other income expense | — | — | — | — | — |
| Pretax income | 284.29M | 606.70M | 443.92M | 91.52M | 148.49M |
| Tax provision | 73.61M | 162.65M | 116.53M | 20.86M | 34.50M |
| Net income | 210.68M | 444.05M | 327.39M | 70.67M | 113.99M |
| Basic EPS | 5.38 | 9.96 | 6.87 | 1.49 | 2.44 |
| Diluted EPS | 5.36 | 9.90 | 6.81 | 1.48 | 2.40 |
| Basic average shares | 39.17M | 44.59M | 47.69M | 47.42M | 46.70M |
| Diluted average shares | 39.17M | 44.59M | 47.69M | 47.42M | 46.70M |
| EBITDA | 499.36M | 784.21M | 581.70M | 243.45M | 235.44M |
| Net income from continuing op. | 210.68M | 444.05M | 327.39M | 70.67M | 113.99M |
| Minority interests | — | — | — | — | — |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 2.92B | 2.89B | 3.13B | 2.35B | 1.93B |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 32.94M | 64.52M | 180.93M | 29.21M | 82.99M |
| Other short term investments | — | — | — | — | — |
| Accounts receivable | 741.19M | 944.38M | 1.03B | 450.08M | 425.40M |
| Other receivables | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Prepaid assets | 21.89M | 18.71M | 72.46M | 13.63M | 11.67M |
| Restricted cash | 22.06M | 37.23M | 29.26M | 18.63M | 18.39M |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | 18.26M | 19.94M | 37.57M | 22.18M | 16.07M |
| Non current assets | |||||
| Properties | 34.54M | 16.27M | 27.77M | 77.74M | 89.87M |
| Land and improvements | — | — | — | — | — |
| Machinery furniture equipment | 460.63M | 374.83M | 308.27M | 268.33M | 228.37M |
| Construction in progress | — | — | — | — | — |
| Leases | 15.84M | 2.07M | 8.80M | 9.60M | 9.37M |
| Accumulated depreciation | -285.08M | -227.62M | -189.95M | -161.75M | -132.90M |
| Goodwill | 2.70B | 2.35B | 2.30B | 2.29B | 1.59B |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | 474.13M | 476.83M | 514.46M | 564.91M | 398.47M |
| Investments and advances | — | — | — | — | — |
| Other non current assets | 271.10M | 216.97M | 221.15M | 196.47M | 182.42M |
| Total liabilities | 2.09B | 1.84B | 1.97B | 1.53B | 1.19B |
| Current liabilities | |||||
| Accounts payable | 177.11M | 373.32M | 339.01M | 107.45M | 102.55M |
| Accrued expenses | 227.62M | 191.29M | 190.30M | 117.41M | 100.12M |
| Short term debt | 7.99M | 8.09M | 11.38M | 19.72M | 13.94M |
| Deferred revenue | 185.58M | 161.76M | 276.67M | 109.82M | 92.85M |
| Tax payable | — | — | 21.16M | — | — |
| Pensions | 44.32M | 108.87M | 117.54M | 44.76M | 31.40M |
| Other current liabilities | 5.74M | 6.86M | 155,000 | 9.30M | 25.30M |
| Non current liabilities | |||||
| Long term debt | 1.34B | 852.87M | 855.69M | 935.76M | 708.37M |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | 23.35M | 22.71M | 47.81M | 67.21M | 46.62M |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 13.32M | 51.15M | 38.32M | 54.98M | 8.92M |
| Shareholders equity | |||||
| Common stock | 504,000 | 501,000 | 498,000 | 496,000 | 493,000 |
| Retained earnings | 1.45B | 1.24B | 796.95M | 469.56M | 400.05M |
| Other shareholders equity | -423,000 | -939,000 | -295,000 | 40,000 | 152,000 |
| Total shareholders equity | 831.26M | 1.04B | 1.16B | 819.68M | 736.74M |
| Additional paid in capital | 506.54M | 501.67M | 486.71M | 468.73M | 455.19M |
| Treasury stock | 1.13B | 698.60M | 121.83M | 119.14M | 119.14M |
| Minority interest | — | — | — | — | — |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||
| Net Income | 210.68M | 444.05M | 327.39M | 70.67M | 113.99M | 141.74M | 132.56M | 105.84M | 81.89M | 33.22M | 32.93M | 15.95M | -26.27M | -51.99M | -122.18M | 34.36M | 36.53M | 35.09M | 22.23M | 17.35M | 37.79M | 52.36M | -4.39M | -5.20M |
| Depreciation | 160.93M | 137.11M | 103.70M | 94.19M | 58.52M | 41.24M | 32.28M | 29.62M | 20.95M | 15.99M | 13.55M | 14.15M | 16.42M | 15.08M | 13.81M | 14.44M | 11.67M | 10.33M | 6.18M | 5.84M | 4.82M | 3.84M | 7.71M | 3.30M |
| Deferred Taxes | -12.93M | -24.62M | -16.29M | -21.63M | 913,000 | -667,000 | 5.61M | -9.42M | 12.68M | 11.78M | 3.03M | 6.95M | -1.80M | -10.71M | -51.72M | -3.37M | 1.14M | 9.32M | 19.02M | 4.09M | 6.04M | 7.30M | -8.65M | -9.73M |
| Stock-Based Compensation | 18.02M | 30.07M | 25.22M | 20.47M | 16.24M | 10.82M | 10.24M | 11.40M | 10.28M | 7.16M | 6.13M | 6.22M | 7.13M | 8.28M | 8.71M | 9.32M | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | 13.34M | 7.37M | -83,000 | 15.26M | 9.76M | -6.67M | 2.42M | 2.39M | 1.60M | 1.39M | 1.34M | 2.92M | 3.79M | 3.24M | 8.92M | 8.02M | 10.42M | 3.90M | 4.63M | — | — | 370,000 | — | — |
| Accounts Receivable | 224.85M | 20.04M | -578.68M | -9.02M | 1.24M | 4.52M | -26.17M | -50.69M | -90.15M | -51.36M | -10.02M | 4.42M | -28.63M | -15.16M | 88.27M | 562,000 | 5.53M | -40.60M | -474,000 | 8.39M | 15.58M | -29.48M | -44.15M | -21.65M |
| Accounts Payable | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Assets & Liabilities | -89.92M | -123.19M | 237.85M | 71.93M | 15.04M | 5.48M | 3.34M | 18.80M | -6.88M | -437,000 | 7.10M | 536,000 | 1.95M | -4.61M | -2.56M | 1.75M | 11.94M | 33.16M | -9.57M | -2.00M | -1.77M | 9.47M | 2.34M | 4.60M |
| Operating Cash Flow | 524.96M | 490.84M | 99.11M | 241.86M | 215.70M | 196.45M | 160.26M | 107.93M | 30.38M | 17.74M | 54.05M | 51.16M | -27.40M | -55.86M | -56.75M | 65.08M | 77.24M | 51.19M | 42.01M | 33.66M | 62.46M | 43.85M | -47.14M | -28.67M |
| Investing Activities | ||||||||||||||||||||||||
| Capital Expenditures | -103.69M | -75.83M | -53.57M | -37.70M | -35.22M | -35.21M | -26.53M | -21.96M | -27.01M | -19.13M | -9.05M | -5.47M | -4.65M | -4.17M | -3.79M | -8.76M | -9.15M | -9.71M | -3.82M | -5.06M | -13.01M | -4.33M | -4.50M | -2.35M |
| Net Intangibles | -1.70M | -5.09M | -90,000 | -1.40M | -1.24M | -1.18M | — | — | — | — | — | — | — | — | — | -40,000 | — | — | — | — | — | — | — | — |
| Net Acquisitions | -292.10M | -69.50M | -41.69M | -476.43M | -247.91M | -217.36M | -1.50M | -218.34M | -85.07M | -14.47M | -39.50M | — | -50,000 | -3.74M | — | -30.95M | -5.48M | -35.96M | -111.51M | — | — | -9.53M | -12.97M | -91.79M |
| Purchase of Investments | — | -13.15M | -60.72M | -48.31M | -26.31M | -39.92M | -17.10M | -13.15M | -1.00M | -5.00M | — | — | — | — | — | — | — | — | — | — | — | — | -16.31M | — |
| Sale of Investments | 9.89M | 14.38M | 57.66M | 33.33M | 32.14M | 25.00M | 20.30M | 2.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | 16.31M | — | — |
| Investing Cash Flow | -410.79M | -165.62M | -107.31M | -536.77M | -290.58M | -278.16M | -35.36M | -258.36M | -116.09M | -28.23M | -49.20M | 1.58M | -1.98M | -6.85M | -29.25M | -48.21M | -14.63M | -45.68M | -115.33M | -5.06M | -14.01M | 1.45M | -33.78M | -94.14M |
| Financing Activities | ||||||||||||||||||||||||
| Long-Term Debt Issuance | — | — | — | 802.00M | 450.00M | — | — | 400.00M | — | 150.00M | — | 198.00M | — | 117.75M | — | — | — | — | — | — | — | — | — | — |
| Long-Term Debt Payments | -355.30M | — | -91.88M | -806.46M | -371.00M | -75.00M | -44.06M | -374.32M | -32.50M | -195.27M | -26.68M | -251.73M | -32.40M | -139.61M | -163.65M | -68.44M | — | — | — | — | — | — | — | — |
| Other Financing Charges | -24.23M | -15.10M | -10.33M | -29.06M | -24.70M | -15.48M | -12.97M | -10.13M | -4.46M | -6.12M | -1.51M | -4.97M | -2.80M | -3.50M | -168,000 | 79,000 | 3.29M | 8.86M | -4.90M | -258,000 | -4.63M | -101,000 | -1.26M | -1.41M |
| Financing Cash Flow | -344.27M | -591.87M | -104.90M | -33.51M | -84.40M | -37.49M | -77.19M | -80.21M | 27.54M | -43.39M | -18.19M | -61.70M | -33.15M | -21.20M | -93.72M | -61.33M | -13.00M | -1.73M | -2.59M | 1.68M | -223.84M | -33.16M | 176.08M | 50.60M |
| Other Cash Details | ||||||||||||||||||||||||
| End Cash Position | 108.27M | 137.87M | 246.71M | 83.99M | 153.96M | 84.32M | 98.89M | 51.03M | 9.58M | 13.07M | 15.58M | 5.68M | 3.96M | 1.88M | 27.05M | 11.32M | 18.50M | 4.42M | 19.11M | 3.91M | 4.69M | 40.14M | 15.65M | 546,000 |
| Income Tax Paid | 78.26M | 213.81M | 106.38M | 46.26M | 37.75M | 30.59M | 73.75M | 73.37M | -33.13M | 17.88M | 18.87M | 1.86M | 388,000 | 84,000 | 5.61M | 32.95M | — | — | — | — | — | — | — | — |
| Interest Paid | 48.10M | 37.52M | 38.09M | 22.65M | 23.73M | 21.28M | 17.94M | 8.06M | -5.81M | 4.60M | 7.41M | 13.70M | 19.67M | 16.43M | 7.39M | 9.60M | — | — | — | — | — | — | — | — |
| Free Cash Flow | 266.78M | 572.81M | 251.69M | 217.72M | 188.40M | 190.61M | 133.99M | 111.95M | 29.30M | 8.54M | 51.12M | 52.91M | 14.66M | 3.92M | 94.94M | 54.90M | 70.49M | 44.82M | 40.27M | 33.98M | 52.13M | 52.53M | -2.82M | -3.94M |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | Nov 30, 2024 | 2,455,488 | 65.34M | 6.45% |
| Fidelity Small Cap Value Fund | Oct 31, 2024 | 1,983,896 | 52.79M | 5.21% |
| Vanguard Total Stock Market Index Fund | Sep 30, 2024 | 1,206,491 | 32.10M | 3.17% |
| Undiscovered Managers Behavioral Value Fund | Sep 30, 2024 | 1,137,868 | 30.28M | 2.99% |
| iShares Russell 2000 ETF | Nov 30, 2024 | 1,059,115 | 28.18M | 2.78% |
| Vanguard Small-Cap Index Fund | Sep 30, 2024 | 952,642 | 25.35M | 2.50% |
| Thrivent Mid Cap Stock Fund | Oct 31, 2024 | 767,399 | 20.42M | 2.02% |
| Vanguard Small Cap Value Index Fund | Sep 30, 2024 | 643,931 | 17.14M | 1.69% |
| Vanguard Extended Market Index Fund | Sep 30, 2024 | 560,831 | 14.92M | 1.47% |
| Thrivent Mid Cap Stock Portfolio | Sep 30, 2024 | 422,986 | 11.26M | 1.11% |
Article
AMN Healthcare to Hold Fourth Quarter and Full Year 2024 Earnings Conference Call on Thursday, February 20, 2025
DALLAS, Jan. 23, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and full year 2024 financial results and first quarter 2025 outlook on Thursday, February 20, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.
Jan 23, 2025
Article
AMN Healthcare: Stock Repurchases, Tech Solutions, Significantly Undervalued
AMN Healthcare Services offers innovative staffing solutions like ShiftWise Flex and AMN Passport, enhancing efficiency and providing tools hospitals and clinics can't develop in-house. Despite recent revenue declines, AMN's historical profitability, positive cash flow, and strategic stock repurchases indicate a strong business model and potential undervaluation. Anticipated EPS growth, potential tax reductions, and continued technological advancements suggest significant upside, with fair value estimates around $42-$43 per share.
Dec 26, 2024
